Regarding “Eteplirsen for the treatment of Duchenne muscular dystrophy”

Annals of Neurology

Volumn 81, Issue 1, 2017, Pages 162-164

  Unger, Ellis F ^a   Califf, Robert M ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; ETEPLIRSEN; MORPHOLINO OLIGONUCLEOTIDE;

COMPUTER; DRUG APPROVAL; DUCHENNE MUSCULAR DYSTROPHY; FOOD AND DRUG ADMINISTRATION; HUMAN; IMAGE ANALYSIS; LETTER; LIGHT EMITTING DIODE; METHODOLOGY; MUSCLE CELL; PATHOLOGIST; PRIORITY JOURNAL; SYSTEMATIC ERROR; TREATMENT OUTCOME;

HUMANS; MORPHOLINOS; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 85010280549     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24842     Document Type: Letter

References (1)

1. Mendell JR, Rodino-Klapac LR, Sahenk Z, et al. Eteplirsen for the treatment of Duchenne muscular dystrophy, Ann Neurol 2013;74:637–647.